Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Name: Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
License: Public Domain

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

nasopharyngeal neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148754
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.